PropertyValue
?:citation
is ?:itemReviewed of
?:keywords
?:mentions
?:text
  • In November 2020, the Canadian government approved the use of psilocybin therapy, which uses the hallucinogenic chemical compound found in psychedelic mushrooms, to ease anxiety and depression associated with a terminal diagnosis. (en)
rdf:type